Key facts
- Notable investors include Plainever Investment & Management, Shandong New Growth Drivers Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Bomaian
- ·The full record, as it builds
Funding rounds
No funding rounds for Bomaian are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bomaian
Manufacturer of interventional balloon catheters designed to support neurovascular and peripheral vascular treatments. The company offers high-pressure and drug-coated balloon catheters, developed through precision engineering and clinical collaboration, which enable hospitals and interventional specialists to manage complex vascular conditions with improved safety and therapeutic effectiveness.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Bomaian doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bomaian shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bomaian in its N-PORT filings yet. We sweep new filings monthly.